The effect of trehalose on intracellular and extracellular nucleotide metabolism. A pilot study

Mikolaj Opielka1, Bartosz Sobocki1, Paulina Mierzejewska1

  • 1Department of Biochemistry, Medical University of Gdansk, Gdansk, Poland.

Insights

Trehalose alters nucleotide metabolism in cancer and endothelial cells, decreasing NAD+ and guanosine levels. This sugar impacts purinergic signaling, suggesting potential therapeutic applications for cancer and endothelial dysfunction.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Cancer Research

Background:

  • Purinergic signaling and nucleotide metabolism are crucial in cancer and inflammation.
  • Trehalose, a disaccharide, has shown potential in modulating autophagy, inflammation, and cancer growth.

Purpose of the Study:

  • To investigate the effect of trehalose on intracellular and extracellular nucleotide and NAD+ metabolism.
  • To compare these effects in endothelial and breast cancer cells.

Main Methods:

  • In vitro treatment of endothelial and breast cancer cells with trehalose.
  • Measurement of intracellular and extracellular nucleotide and NAD+ levels.
  • Assay of ecto-adenosine deaminase activity.

Main Results:

  • Trehalose (0.5–5 mM) reduced intracellular NAD+ in breast cancer cells.
  • Decreased intracellular guanosine was observed in both cell types.
  • Trehalose significantly inhibited ecto-adenosine deaminase activity, reducing adenosine deamination by up to 3-fold.
  • Metabolic changes were more pronounced in cancer cells than in endothelial cells.

Conclusions:

  • Trehalose alters nucleotide metabolism in both endothelial and cancer cells, with a greater impact on cancer cells.
  • These findings suggest a potential therapeutic role for trehalose in cancer and endothelial dysfunction.
  • Further research is needed to fully elucidate these effects and their therapeutic implications.

Related Concept Videos